GPC Biotech, Inc.
610 Lincoln Street
Waltham
Massachusetts
02451
United States
Tel: 781-890-9007
Fax: 781-890-9005
Website: http://www.gpc-biotech.com/
Email: info@gpc-biotech.com
13 articles about GPC Biotech, Inc.
-
GPC Biotech, Inc.: New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at American Association for Cancer Research
4/21/2009
-
GPC Biotech AG to Present at JPMorgan 26th Annual Healthcare Conference in San Francisco
12/20/2007
-
GPC Biotech AG Restructures US Operations, Cuts 15 Percent of Workforce
8/23/2007
-
GPC Biotech, Inc. Withdraws Satraplatin NDA For Accelerated Approval; Plans to Resubmit With Survival Analysis
7/30/2007
-
GPC Biotech, Inc. Reports Financial Results For Third Quarter And First Nine Months Of 2006
11/9/2006
-
GPC Biotech, Inc. Meeting And Conference Call On Results For The Third Quarter And First Nine Months Of 2006 Scheduled For November 9th
11/2/2006
-
GPC Biotech, Inc. To Present At Two Upcoming Conferences
10/30/2006
-
The Week In Review: Biotech Ends Q3 With A Bang
10/2/2006
-
The Day In Review: Pozen, Inc. Inks Pain Deal With AstraZeneca PLC
8/2/2006
-
The Day In Review: FDA Approves Merck & Co., Inc.’s Gardasil
6/8/2006
-
GPC Biotech, Inc. Release: Orphan Drug Designation Granted By European Commission For Anticancer Monoclonal Antibody 1D09C3 For Chronic Lymphocytic Leukemia
1/27/2006
-
GPC Biotech, Inc. Announces Start of Phase 2 Trial Evaluating Satraplatin Plus Taxol(r) In Patients With Advanced Non-Small Cell Lung Cancer
12/12/2005
-
GPC Biotech, Inc. Meeting And Conference Call On Results For The Third Quarter And First Nine Months Of 2005 Scheduled For November 3rd
10/28/2005